Overview

• The Karnataka Food Safety and Drug Administration classified 15 products as failing quality tests conducted by its Drugs Testing Laboratory in May 2025.
• Affected items include Ringer-Lactate Injection IP by Ultra Laboratories and Tam Bran, Pomol-650 Paracetamol tablets by Aban Pharmaceuticals, and MITO Q7 syrup by Bion Therapeutics India.
• Health Minister Dinesh Gundu Rao directed chemists, hospitals, and nursing homes to halt stocking and distribution of listed items and inform local regulators of remaining supplies.
• The public has been urged to avoid using the flagged drugs and cosmetics under threat of strict enforcement measures for noncompliance.
• The action dovetails with India’s broader effort to expand production-linked incentive schemes aimed at boosting domestic pharmaceutical quality and curbing reliance on imports from China.